IJUP08 - Universidade do Porto
IJUP08 - Universidade do Porto
IJUP08 - Universidade do Porto
- TAGS
- universidade
- porto
- ijup.up.pt
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Angiogenesis modulation by catechin<br />
Duarte DD, Silva RP, Azeve<strong>do</strong> I, Soares R and Negrão R<br />
Department of Biochemistry (U38/FCT), Faculty of Medicine, University of <strong>Porto</strong>, Portugal.<br />
Angiogenesis, the formation of new blood vessels from pre-existing ones, is a process that<br />
occurs in many physiological conditions, like wound healing and pregnancy, but also in<br />
pathological situations such as cancer and cardiovascular disease. Deficient angiogenesis<br />
results in deficient blood flow as in coronary heart disease and acute myocardial infarction.<br />
Recent Western diet is believed to contribute to an increased lifetime risk of cancer and<br />
cardiovascular disorders. On the other hand, diets high in plant-derived foods offer a<br />
protective effect. Recent studies indicate that the development of these pathologies is<br />
inversely associated with the consumption of natural polyphenolic compounds, which are<br />
known to affect angiogenesis. Identification and characterization of dietary phytochemicals<br />
able to block, slow or reverse angiogenesis may, thus, constitute an important strategy for<br />
prevention of cancer and cardiovascular disease. Catechin is a bioactive phytochemical<br />
abundant in some beverages like tea and wine and also in fruits and vegetables.<br />
The purpose of this study was to investigate the effect of catechin in angiogenesis, namely<br />
evaluating its effects on human umbilical vein en<strong>do</strong>thelial cells (HUVEC) and human<br />
aortic smooth muscle cells (HASMC) viability, apoptosis, proliferation, migration,<br />
invasion and also capillary-like structures formation.<br />
Treatment of cells with 10-100 µM catechin resulted in a significant increase in both<br />
HUVEC (165.34±31.12%) and HASMC (165.58±5.04%) viability assessed by MTT (3-<br />
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay and confirmed by<br />
measuring lactate dehydrogenase activity released to the extracellular medium.<br />
Furthermore, the number of apoptotic cells determined by TUNEL (Terminal<br />
deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling) assay<br />
diminished slightly in HUVEC (to 46.55±12.88%), and drastically in HASMC (to<br />
7.35±4.85%). Proliferation evaluation by measuring Brdu cellular incorporation as well as<br />
determination of cell invasive capacity using Transwell BD-Matrigel basement membrane<br />
matrix insert are still under analysis. Catechin treatment led to a slight reduction in<br />
HASMC cell migration to injured areas (injury assay) but it seemed to increase HUVEC<br />
migration in the same conditions. Incubation of HUVEC on growth factor reduced-<br />
Matrigel-coated plates for 24 h with 10 µM catechin led to the formation of highly<br />
ramified cord-like structures (174.07% ±14.93%).<br />
The results obtained so far indicate that catechin decreased cell apoptosis and exerted<br />
stimulatory effects on en<strong>do</strong>thelial and vascular smooth muscle cell’s viability and on<br />
HUVEC migration and capillary-like structures formation, processes that are required for<br />
the development of physiological and pathological angiogenesis.<br />
Supported by ERAB (EA0641) and FCT (POCTI/SAU-BMA/55556/2004).<br />
8